XML 88 R76.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCKHOLDERS' EQUITY (DEFICIT) (Series A Senior Preferred Stock) (Details) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 29, 2017
Aug. 31, 2017
Jun. 30, 2016
Dec. 31, 2017
Dec. 31, 2016
Class of Stock [Line Items]          
Preferred stock, shares authorized (in shares)       15,000,000 1,294,434
Preferred stock, par value (in dollars per share)       $ 0.01 $ 0.01
Preferred stock, dividend rate (percentage)     8.00%    
Shares converted, value $ 3,000,000       $ 433,000
New shares issued (in shares)   22,518      
Number of shares converted (in shares)   1,735,419      
Warrants, fair value $ 211,000   $ 1,421,738    
Issuance of warrants   $ 84,000,000   $ 7,784,000  
Preferred stock, shares outstanding (in shares)       4,935 780,105
Preferred stock, shares issued (in shares)       4,935 780,105
Private Placement          
Class of Stock [Line Items]          
New shares issued (in shares) 107,056        
Consideration received $ 400,000        
Transgenomics [Member]          
Class of Stock [Line Items]          
Shares converted, value $ 3,000,000        
Preferred stock - series A senior          
Class of Stock [Line Items]          
Preferred stock, shares authorized (in shares) 4,100,000     4,100,000  
Preferred stock, par value (in dollars per share) $ 0.01        
Conversion price (in dollars per share)       $ 3.736329  
Conversion of stock, discount rate       15.00%  
Preferred stock, dividend rate (percentage)       8.00%  
Deemed dividend       $ 5,200,000  
Number of shares converted (in shares)   1,712,901      
Warrants, fair value   $ 1,400,000      
Preferred stock, shares outstanding (in shares)       0  
Preferred stock, shares issued (in shares)       1,712,901  
Preferred Stock [Member]          
Class of Stock [Line Items]          
Number of shares converted from debt instrument (in shares) 802,920        
Number of shares converted (in shares) 7,155        
Preferred Stock [Member] | Private Placement          
Class of Stock [Line Items]          
New shares issued (in shares) 107,056        
Preferred Stock [Member] | Transgenomics [Member]          
Class of Stock [Line Items]          
Number of shares converted from debt instrument (in shares) 802,925        
Common Stock [Member]          
Class of Stock [Line Items]          
Number of shares converted from debt instrument (in shares) 1,414,700        
Number of shares converted (in shares) 5,352,847        
Stock rights issued (in shares)   856,446